Exelon Corp: Form 10-K for the period ended Dec 31, 2013
Filed with the SEC on Feb 14, 2014 and accepted by EDGAR at Feb 14, 2014, 00:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-10-01 to 2013-12-31 | $6.16bn | us-gaap:Revenues |
| Revenue | 12 months2013-01-01 to 2013-12-31 | $24.89bn | us-gaap:Revenues |
| Operating income | 12 months2013-01-01 to 2013-12-31 | $3.66bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2013-01-01 to 2013-12-31 | $1.31bn | us-gaap:InterestExpense |
| Income tax | 12 months2013-01-01 to 2013-12-31 | $1.04bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-10-01 to 2013-12-31 | $495.0m | us-gaap:ProfitLoss |
| Net income | 12 months2013-01-01 to 2013-12-31 | $1.73bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2013-10-01 to 2013-12-31 | $0.59 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2013-01-01 to 2013-12-31 | $2.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-10-01 to 2013-12-31 | $0.60 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-10-01 to 2013-12-31 | 860,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 12 months2013-01-01 to 2013-12-31 | 860,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2013-01-01 to 2013-12-31 | $6.34bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2013-01-01 to 2013-12-31 | $5.39bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2013-01-01 to 2013-12-31 | $1.25bn | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2013-12-31 | $1.61bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-12-31 | $10.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $79.92bn | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $7.73bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-12-31 | $56.98bn | us-gaap:Liabilities |
| Long-term debt | At period end2013-12-31 | $17.32bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2013-12-31 | $341.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2013-12-31 | $22.73bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2013-12-31 | 857,419,806 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-14-051838. Last ingested by Listed: Nov 14, 2026, 14:06 ET. Listed shows no prices and gives no investment advice.